全文获取类型
收费全文 | 4033篇 |
免费 | 417篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 119篇 |
妇产科学 | 71篇 |
基础医学 | 565篇 |
口腔科学 | 63篇 |
临床医学 | 626篇 |
内科学 | 878篇 |
皮肤病学 | 40篇 |
神经病学 | 305篇 |
特种医学 | 348篇 |
外科学 | 364篇 |
综合类 | 65篇 |
一般理论 | 15篇 |
预防医学 | 467篇 |
眼科学 | 91篇 |
药学 | 178篇 |
中国医学 | 5篇 |
肿瘤学 | 242篇 |
出版年
2021年 | 56篇 |
2020年 | 43篇 |
2019年 | 56篇 |
2018年 | 72篇 |
2017年 | 61篇 |
2016年 | 83篇 |
2015年 | 68篇 |
2014年 | 82篇 |
2013年 | 104篇 |
2012年 | 162篇 |
2011年 | 172篇 |
2010年 | 124篇 |
2009年 | 142篇 |
2008年 | 179篇 |
2007年 | 180篇 |
2006年 | 185篇 |
2005年 | 134篇 |
2004年 | 146篇 |
2003年 | 129篇 |
2002年 | 115篇 |
2001年 | 108篇 |
2000年 | 116篇 |
1999年 | 99篇 |
1998年 | 91篇 |
1997年 | 83篇 |
1996年 | 86篇 |
1995年 | 74篇 |
1994年 | 65篇 |
1993年 | 74篇 |
1992年 | 85篇 |
1991年 | 76篇 |
1990年 | 78篇 |
1989年 | 104篇 |
1988年 | 83篇 |
1987年 | 85篇 |
1986年 | 75篇 |
1985年 | 89篇 |
1984年 | 56篇 |
1983年 | 41篇 |
1982年 | 43篇 |
1981年 | 45篇 |
1980年 | 33篇 |
1979年 | 48篇 |
1978年 | 42篇 |
1977年 | 43篇 |
1976年 | 37篇 |
1975年 | 40篇 |
1974年 | 32篇 |
1973年 | 28篇 |
1971年 | 23篇 |
排序方式: 共有4460条查询结果,搜索用时 15 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. 总被引:7,自引:0,他引:7
In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6). We also detected high levels of annexin II expression in fetal brain during the period when radial glia proliferate, although annexin II expression was not detected in normal adult brain. These data demonstrate that annexin II expression is developmentally regulated in the human central nervous system and suggest that the early progenitor radial glia share important characteristics with highly malignant glial tumors. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
B. L. Kirkpatrick S. C. Glover D. S. Reeves A. P. MacGowan 《Postgraduate medical journal》1997,73(863):565-570
We have reviewed the incidence, type and site of microbiologically proven bacterial infection occurring in 52 patients with the acquired immunodeficiency syndrome (AIDS) who presented to Southmead Hospital, Bristol between 1990 and 1994. A total of 30 (58%) patients had significant bacterial isolates. The majority of infections were community acquired. Overall, more infections were caused by Gram-negative organisms but Gram-positive organisms predominated in bacteraemia. Mycobacterium avium intracellulare (MAI) caused infection in the largest number of patients, followed by Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas sp, and Campylobacter sp. When individual episodes of infection were considered, after MAI, Haemophilus influenzae, Streptococcus pneumoniae and Pseudomonas sp were the organisms most frequently isolated; often these same organisms caused recurrent chest infection. Bacterial infections in AIDS patients are common and although they generally respond well to antimicrobial chemotherapy there is a high recurrence rate, particularly in the respiratory tract, which is the commonest site of infection. 相似文献